Related Experiment Videos
Occult node metastases in head and neck squamous carcinoma
A S Jones1, D E Phillips, T R Helliwell
1Department of Otorhinolaryngology, University of Liverpool, Royal Liverpool University Hospital, UK.
Summary
In head and neck cancers, 32% of clinically node-negative (N0) necks had occult squamous cell carcinoma. Early surgical treatment versus watchful waiting did not improve survival for these patients.
Area of Science:
- Oncology
- Head and Neck Surgery
- Pathology
Background:
- Head and neck cancers often present with clinically node-negative (N0) necks.
- The presence of subclinical squamous cell carcinoma in these N0 necks is a significant concern.
- Management strategies range from observation to prophylactic neck dissection.
Purpose of the Study:
- To determine the proportion of N0 necks with subclinical squamous cell carcinoma (SCC) across various head and neck primary sites.
- To evaluate if empiric treatment of occult disease improves survival compared to a "wait-and-watch" policy.
Main Methods:
- Retrospective analysis of the Liverpool database.
- Examination of 117 neck dissections for N0 necks.
- Comparison of survival outcomes between treated and untreated N0 necks for pyriform fossa cancers.
- Analysis of survival in a larger cohort of patients with no clinical neck node metastases.
Main Results:
- 32% of N0 neck dissections harbored squamous cell carcinoma.
- Highest risk was observed in hypopharyngeal cancers (50% with pyriform fossa primary).
- No significant survival difference was found between radical neck dissection and non-treatment for N0 pyriform fossa cancers (P = NS).
- No survival difference was observed in a larger cohort comparing neck dissection versus no neck dissection for clinically node-negative patients (P = NS).
Conclusions:
- Subclinical squamous cell carcinoma is prevalent in N0 necks of head and neck cancer patients.
- Empiric treatment of N0 necks does not appear to improve survival over a "wait-and-watch" approach.
- Further research may refine management strategies for clinically node-negative necks in head and neck oncology.